Bioxera Pharma Pvt. Ltd.

Main products: Amylmetacresol,2,4-Dichlorobenzyl Alcohol,Benfotiamine,Clomifene Citrate,Tamoxifen Citrate

Current Location: HOME >> Enterprise Certification

Contact information

  • TEL:+91-8655904613
  • Email:info@bioxerapharma.com

Company Profile

Established as one of the leading names in API manufacturing and intermediates, BioXera Pharma specialises in the development of innovative processes for a wide range of products. The business comprises of manufacture and sales of APIs and intermediates in both domestic and international markets, including the regulated markets. With a strong R&D, technology, word class infrastructure, headed by a team of technocrats, BioXera has established a large portfolio of molecules in the commercial production along with several more in the pipeline. With the ability to handle complex chemical synthesis, BioXera has built up strength in the development, process optimisation and cGMP production of APIs and intermediates. At BioXera, in every aspect of work, quality assurance is an attitude of seeking sustainable betterment. Today BioXera offers API and intermediates to over 13 countries, and are poised to enter more shortly.

Enterprise Basic Information

Enterprise Certification

Type of Enterprise: Manufacturer
Legal Representative: Bioxera Pharma Pvt. Ltd.
Registered Capital: 10 Lakhs
Founded Date: 2021-03-01
Registered Address: "Arex House,_x000D_ 21, Sitladevi Temple Road,_x000D_ Mahim, Mumbai, Maharashtra-400016, India."
Term of Validity: 2021-03-01—2050-03-01
Business Scope: CHEMICALS
Staff number: 1-10 People
Number of R & D department: 1-5
Annual turnover: INR Below INR 1 million
Main consumer market: Pharmaceutical factory 
Main marketing location: India 
Main product or service: PRODUCTS